CLINICAL MANIFESTATIONS OF CUSHING'S DISEASE (RESULTS OF ANALYSIS OF THE CLINICAL DATABASE OF THE MOSCOW REGION)

Cover Page


Cite item

Full Text

Abstract

Background: Cushing's disease (CD) is a  severe multimorbid disorder that affects primarily young people in their productive age. In most cases, the diagnosis is delayed and patients with complications of hypercorticism are seen by doctors of various specialties.

Aim: To identify the most frequent clinical signs and symptoms of CD at the time of diagnosis, to assess an association between clinical manifestations of hypercorticism and main clinical and laboratory parameters.

Materials and methods: We examined 44 CD patients registered in the database of CD patients of the Moscow Regional Research and Clinical Institute (MONIKI).

Results: The mean age of patients was 37.9±10.5 years, with most of them (68.2%) being in the age range of 30 to 50 years. The median of disease duration was 35.5 [22; 75] months. Facial plethora, which is the most characteristic sign of hypercorticism, was seen in 97.7% of patients. Striae, thought to be most often associated with hypercorticism, were found only in 38.6% of patients. The most frequent complaints (> 80%) were weight gain, fatigue, headache, and menstrual dysfunction. Some of the symptoms showed a positive correlation with cortisol levels.

Conclusion: Clinical manifestations of CD are mostly non-specific. Only facial plethora was highly prevalent of all typical symptoms of hypercorticism. At least one of the "specific" symptoms was found in all patients.

About the authors

I. V. Komerdus

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: komerdus@gmail.com

MD, PhD, Associate Professor, Chair of Endocrinology, Postgraduate Training Faculty,

61/2 Shchepkina ul., Moscow, 129110

Russian Federation

A. V. Dreval'

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Professor, Head of Department of Therapeutic Endocrinology; Chief of Chair of Endocrinology, Postgraduate Training Faculty,

61/2 Shchepkina ul., Moscow, 129110

Russian Federation

A. V. Chekanova

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, Endocrinologist, Department of Therapeutic Endocrinology,

61/2 Shchepkina ul., Moscow, 129110

Russian Federation

L. A. Akulkina

Lomonosov Moscow State University

Email: fake@neicon.ru

Student, Faculty of Basic Medicine,

1 Leninskie gory, Moscow,119991

Russian Federation

References

  1. Дедов ИИ, Мельниченко ГА, ред. Болезнь Иценко – Кушинга. М.: УП Принт; 2011. 342 с.
  2. Дедов ИИ, ред. Клиническая нейроэндокринология. М.: УП Принт; 2011. 343 с.
  3. Белая ЖЕ, Рожинская ЛЯ, Драгунова НВ, Дзеранова ЛК, Марова ЕИ, Арапова СД, Молитвословова НН, Зенкова ТС, Мельниченко ГА, Дедов ИИ. Метаболические осложнения эндогенного гиперкортицизма. Выбор пациентов для скрининга. Ожирение и метаболизм. 2013;(1):26–31.
  4. Трошина ЕА, Бельцевич ДГ, Молашенко НВ, Газизова ДО. Диагностика, дифференциальная диагностика и лечение эндогенного гиперкортицизма. Проблемы эндокринологии. 2010;56(2):53–63.
  5. Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM; ERCUSYN Study Group. The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol. 2011;165(3):383–92. doi: 10.1530/EJE-11-0272.
  6. Nieman LK, Biller BMK, Finding JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526–40. doi: 10.1210/jc.2008-0125.
  7. Древаль АВ, Комердус ИВ, Музурина АВ, Нечаева ОА, Тишенина РС, Бородина ЕГ, Анашкина ГА. Распространенность субклинического гиперкортицизма среди больных с сахарным диабетом 2-го типа и алиментарным ожирением. Проблемы эндокринологии. 2014;60(1):9–17. doi: 10.14341/probl20146019-17.
  8. Badia X, Valassi E, Roset M, Webb SM. Disease-specific quality of life evaluation and its determinants in Cushing's syndrome: what have we learnt? Pituitary. 2014;(2):187–95. doi: 10.1007/s11102-013-0484-2.
  9. Tang A, O'Sullivan AJ, Diamond T, Gerard A, Campbell P. Psychiatric symptoms as a clinical presentation of Cushing's syndrome. Ann Gen Psychiatry. 2013;12(1):23. doi: 10.1186/1744-859X-12-23.
  10. Bruno OD, Juárez-Allen L, Rossi MA, Longobardi V. In what clinical settings should Cushing's syndrome be suspected? Medicina (B Aires). 2009;69(6):674–80.
  11. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf). 1994;40(4):479–84. doi: 10.1111/j.1365-2265.1994.tb02486.x.
  12. Дедов ИИ, Мельниченко ГА, Фадеев ВВ. Эндокринология: учебник. М.: Медицина; 2000. 432 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Komerdus I.V., Dreval' A.V., Chekanova A.V., Akulkina L.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies